Livaracine®
Active Ingredient:
Low Molecular Weight Heparin
Indication:
Heart disease and other cardiovascular diseases

Hefei Manufacturing Site

Site Profile

In operation since 1998, 4,600m2 manufacturing area
The construction of liposome production line and biologics drug substance production line have been completed 
A new laboratory animal center has commenced operation which can accommodate various animal tests on products such as surfactants, calf blood extractives or snake venom extractives 

Innovation, Excellence and Resilience

Topical gel
Eye gel/drop
Liposome
Small volume injection
New Pre-filled syringe facility
Biologics drug substance
Lyophilized powder for injection

Nansha Manufacturing Site

Site Profile

Construction completed in 2015, 50,000m2 manufacturing area
Obtained manufacturing license of multi-dose production line in July 2018
Obtained manufacturing license of mono-dose production line utilised blow-fill-seal technology in September 2018
Obtained one additional manufacturing license for the production of cytotoxic capsules in October 2018 

Production Line

Solid dose
Ophthalmic drug
Cytotoxic capsule 
Medical Device (Planning)